International Journal of Internal Medicine

Objective To investigate the intervention significance of butylphthalide injection combined with edaravone in the treatment of patients with acute cerebral infarction. Methods the subjects were 80 patients with acute cerebral infarction who were treated in the hospital from April 2020 to April 2022. They were divided into groups by random number table method. One group was set as the control group, with 40 cases, using conventional therapy, and the other group was set as the observation group, with 40 patients between the groups. Butylphthalide injection and edaravone were used to compare the differences in the total efficacy, neurological function and ADL between the groups. Results the total effective rate in the control group was higher than that in the control group (P＜0.05; The score of neurological function in the observation group was lower than that in the control group, and the score of ADL in the observation group was higher than that in the control group (P<0.05). Conclusion the combination of butylphthalide injection and edaravone can effectively alleviate the symptoms of patients, improve the neurological function of patients and enhance their self-care ability, which is suitable for clinical application.

Acute cerebral infarction; Edaravone; Butylphthalide injection; Therapeutic effect; Nerve function; Ability of daily living